Powered by

Shoreline Biosciences Appoints Mohammad El-Kalay, Ph.D. As Senior VP And Head Of CMC

Jun 28, 2021 - PR Newswire
Board and Executive Moves

PR Newswire

 Shoreline Biosciences, Inc. (Shoreline), a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized, and targeted induced pluripotent stem cells (iPSC) derived natural killer (NK) and Macrophage cellular immunotherapies, today announced the appointment of Mohammad El-Kalay, Ph.D., as Senior VP and Head of CMC (Chemistry, Manufacturing, and Control).  

Dr. El-Kalay brings over three decades of experience in global biopharmaceutical ...